Actinium Pharmaceuticals
ATNM
#10613
Rank
HK$0.19 B
Marketcap
HK$6.26
Share price
1.32%
Change (1 day)
-45.79%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -HK$0.2 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are HK$0.09 Million. In 2025 the company made an earning of -HK$0.29 Billion, an increase over its 2024 earnings that were of -HK$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.2 Billion-29.89%
2025 -HK$0.29 Billion-13.95%
2024 -HK$0.34 Billion-18.87%
2023 -HK$0.41 Billion52.24%
2022 -HK$0.27 Billion36.61%
2021 -HK$0.2 Billion11.48%
2020 -HK$0.18 Billion1.46%
2019 -HK$0.18 Billion-7.37%
2018 -HK$0.19 Billion-11.46%
2017 -HK$0.22 Billion10.67%
2016 -HK$0.2 Billion15.7%
2015 -HK$0.17 Billion-14.86%
2014 -HK$0.2 Billion129.19%
2013 -HK$84.51 Million-8.55%
2012 -HK$92.41 Million
2010 HK$0.06 M-152.15%
2009 -HK$0.13 Million-39.8%
2008 -HK$0.21 Million120.29%
2007 -HK$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-HK$0.3 Billion 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$1.49 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$3.02 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA